IN2014MN00971A - - Google Patents

Info

Publication number
IN2014MN00971A
IN2014MN00971A IN971MUN2014A IN2014MN00971A IN 2014MN00971 A IN2014MN00971 A IN 2014MN00971A IN 971MUN2014 A IN971MUN2014 A IN 971MUN2014A IN 2014MN00971 A IN2014MN00971 A IN 2014MN00971A
Authority
IN
India
Prior art keywords
producing
formula
alkyl group
acceptable salt
raw material
Prior art date
Application number
Other languages
English (en)
Inventor
Tomohito Sakurai
Takumi Nakajima
Masakazu Wakayama
Fumihiko Toriyama
Yasuhisa Kuwahara
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of IN2014MN00971A publication Critical patent/IN2014MN00971A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN971MUN2014 2011-12-16 2012-12-13 IN2014MN00971A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011275819 2011-12-16
PCT/JP2012/082294 WO2013089168A1 (ja) 2011-12-16 2012-12-13 ノイラミン酸誘導体の製造方法

Publications (1)

Publication Number Publication Date
IN2014MN00971A true IN2014MN00971A (ru) 2015-05-22

Family

ID=48612610

Family Applications (1)

Application Number Title Priority Date Filing Date
IN971MUN2014 IN2014MN00971A (ru) 2011-12-16 2012-12-13

Country Status (12)

Country Link
US (2) US20140356625A1 (ru)
EP (3) EP2960237A1 (ru)
JP (1) JP6038808B2 (ru)
KR (1) KR101971311B1 (ru)
CN (3) CN105037309A (ru)
BR (1) BR112014014635A2 (ru)
CA (1) CA2859296C (ru)
ES (1) ES2640001T3 (ru)
HK (3) HK1218911A1 (ru)
IL (2) IL233124A0 (ru)
IN (1) IN2014MN00971A (ru)
WO (1) WO2013089168A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111018901B (zh) * 2013-09-09 2021-09-03 中国科学院上海有机化学研究所 扎那米韦和拉那米韦的中间体及其合成方法
CN113801138A (zh) * 2020-06-12 2021-12-17 博瑞生物医药(苏州)股份有限公司 一种一锅法制备辛酸拉尼米韦中间体的方法
CN113801082B (zh) * 2020-06-12 2024-09-17 博瑞生物医药(苏州)股份有限公司 一种辛酸拉尼米韦的制备方法
KR102405310B1 (ko) * 2020-07-08 2022-06-02 가톨릭대학교 산학협력단 유체의 압력을 이용한 인공 요도괄약근
CN114907301B (zh) * 2021-02-10 2024-05-28 上海医药工业研究院 一种拉尼米韦辛酸酯中间体及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5141897B2 (ru) 1972-11-30 1976-11-12
JP2745059B2 (ja) * 1989-03-08 1998-04-28 メクト株式会社 N―アセチルノイラミン酸ナトリウム・三水和物
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
JPH0994768A (ja) * 1995-09-29 1997-04-08 Nippon Electric Ind Co Ltd 車用電動工具
ATE211468T1 (de) * 1996-07-22 2002-01-15 Sankyo Co Neuraminsäuredervate, ihre herstellung und medizinische verwendung
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
JP3209946B2 (ja) 1996-07-22 2001-09-17 三共株式会社 ノイラミン酸誘導体
US6451766B1 (en) * 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US7330875B1 (en) 1999-06-15 2008-02-12 Microsoft Corporation System and method for recording a presentation for on-demand viewing over a computer network
JP4205314B2 (ja) 2000-04-25 2009-01-07 第一三共株式会社 インフルエンザ予防剤
WO2001080892A1 (fr) 2000-04-25 2001-11-01 Sankyo Company, Limited Substances preventives de la grippe
JP3920041B2 (ja) 2000-04-25 2007-05-30 三共株式会社 ノイラミン酸化合物の水和物及び結晶
TWI291462B (en) * 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
TWI389895B (zh) * 2006-08-21 2013-03-21 Infinity Discovery Inc 抑制bcl蛋白質與結合夥伴間之交互作用的化合物及方法
KR101473028B1 (ko) * 2007-03-07 2014-12-15 다이이찌 산쿄 가부시키가이샤 인플루엔자 치료제
TWI460182B (zh) * 2007-04-11 2014-11-11 Daiichi Sankyo Co Ltd 原酸酯之製造方法
TWI491416B (zh) * 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
CN102050771A (zh) * 2009-11-05 2011-05-11 沈阳万爱普利德医药科技有限公司 一个一种前列腺素衍生物的制造方法

Also Published As

Publication number Publication date
IL236766A0 (en) 2015-03-31
HK1218912A1 (zh) 2017-03-17
EP2960237A1 (en) 2015-12-30
EP2960236B1 (en) 2017-06-14
KR20140102216A (ko) 2014-08-21
CN104926802B (zh) 2018-02-13
EP2792676A1 (en) 2014-10-22
CA2859296C (en) 2016-10-11
EP2960236A1 (en) 2015-12-30
HK1218911A1 (zh) 2017-03-17
CN103974945A (zh) 2014-08-06
WO2013089168A1 (ja) 2013-06-20
JPWO2013089168A1 (ja) 2015-04-27
CN105037309A (zh) 2015-11-11
US20170114035A1 (en) 2017-04-27
CN104926802A (zh) 2015-09-23
JP6038808B2 (ja) 2016-12-07
CA2859296A1 (en) 2013-06-20
EP2792676A4 (en) 2015-10-07
US20140356625A1 (en) 2014-12-04
HK1199034A1 (en) 2015-06-19
KR101971311B1 (ko) 2019-04-22
BR112014014635A2 (pt) 2017-06-13
ES2640001T3 (es) 2017-10-31
IL233124A0 (en) 2014-08-03
CN103974945B (zh) 2016-03-09

Similar Documents

Publication Publication Date Title
PH12017501426A1 (en) Derivatives of betulin
MX2015005286A (es) Procedimiento para la preparación de derivados del ácido biliar.
HK1166073A1 (en) Thienopyrimidinedione derivatives as trpa1 modulators
MX2012003343A (es) Proceso para preparar compuestos azabiciclicos.
MD20180040A2 (ru) Ингибиторы вируса гепатита С
IN2012DN02751A (ru)
EA201500173A1 (ru) Фунгицидные композиции
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
MX2013011257A (es) Proceso para la preparacion de dronedarona por n-butilacion.
NZ603268A (en) Process for synthesizing oxidized lactam compounds
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
EP2590649A4 (en) PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES
WO2013014665A8 (en) Intermediate compounds and process for the preparation of lurasidone and salts thereof
IN2014DN00144A (ru)
MX2012001411A (es) Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico.
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
IN2014MN00971A (ru)
WO2012140490A3 (en) Processes for preparing pitavastatin calcium
MX2014004688A (es) Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos.
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
MX364529B (es) Nuevos ligandos del receptor de estrógeno.
IN2014DN09451A (ru)
WO2013072938A3 (en) Process for the preparation of roflumilast
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.
IN2012DN02000A (ru)